ID   PI42C_HUMAN             Reviewed;         421 AA.
AC   Q8TBX8; B2RDL3; B4DM11; B4DY44; Q9H6N2;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   12-APR-2017, entry version 129.
DE   RecName: Full=Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma;
DE            EC=2.7.1.149;
DE   AltName: Full=Phosphatidylinositol 5-phosphate 4-kinase type II gamma;
DE            Short=PI(5)P 4-kinase type II gamma;
DE            Short=PIP4KII-gamma;
GN   Name=PIP4K2C; Synonyms=PIP5K2C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Placenta, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-241.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26 AND SER-349, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 32-421.
RG   Structural genomics consortium (SGC);
RT   "Structure of human phosphatidylinositol-4-phosphate 5-kinase, type
RT   II, gamma.";
RL   Submitted (APR-2007) to the PDB data bank.
CC   -!- FUNCTION: May play an important role in the production of
CC       Phosphatidylinositol bisphosphate (PIP2), in the endoplasmic
CC       reticulum. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 5-
CC       phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1383637, EBI-1383637;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane. Note=Mostly found in
CC       the cytosol and surrounding plasma membrane. However, its presence
CC       in the endoplasmic reticulum seems to be a prerequisite for PIP2
CC       synthesis (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TBX8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TBX8-2; Sequence=VSP_042929;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8TBX8-3; Sequence=VSP_043369;
CC         Note=No experimental confirmation available.;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15223.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK025708; BAB15223.1; ALT_INIT; mRNA.
DR   EMBL; AK297243; BAG59723.1; -; mRNA.
DR   EMBL; AK302254; BAG63606.1; -; mRNA.
DR   EMBL; AK315588; BAG37960.1; -; mRNA.
DR   EMBL; AC022506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97031.1; -; Genomic_DNA.
DR   EMBL; BC028596; AAH28596.1; -; mRNA.
DR   CCDS; CCDS53808.1; -. [Q8TBX8-2]
DR   CCDS; CCDS55839.1; -. [Q8TBX8-3]
DR   CCDS; CCDS8946.1; -. [Q8TBX8-1]
DR   RefSeq; NP_001139730.1; NM_001146258.1. [Q8TBX8-1]
DR   RefSeq; NP_001139731.1; NM_001146259.1. [Q8TBX8-3]
DR   RefSeq; NP_001139732.1; NM_001146260.1. [Q8TBX8-2]
DR   RefSeq; NP_079055.3; NM_024779.4. [Q8TBX8-1]
DR   UniGene; Hs.745011; -.
DR   PDB; 2GK9; X-ray; 2.80 A; A/B/C/D=32-421.
DR   PDBsum; 2GK9; -.
DR   ProteinModelPortal; Q8TBX8; -.
DR   SMR; Q8TBX8; -.
DR   BioGrid; 122928; 37.
DR   IntAct; Q8TBX8; 2.
DR   STRING; 9606.ENSP00000347032; -.
DR   BindingDB; Q8TBX8; -.
DR   ChEMBL; CHEMBL1770034; -.
DR   GuidetoPHARMACOLOGY; 2163; -.
DR   iPTMnet; Q8TBX8; -.
DR   PhosphoSitePlus; Q8TBX8; -.
DR   BioMuta; PIP4K2C; -.
DR   DMDM; 317373532; -.
DR   EPD; Q8TBX8; -.
DR   MaxQB; Q8TBX8; -.
DR   PaxDb; Q8TBX8; -.
DR   PeptideAtlas; Q8TBX8; -.
DR   PRIDE; Q8TBX8; -.
DR   DNASU; 79837; -.
DR   Ensembl; ENST00000354947; ENSP00000347032; ENSG00000166908. [Q8TBX8-1]
DR   Ensembl; ENST00000422156; ENSP00000412035; ENSG00000166908. [Q8TBX8-2]
DR   Ensembl; ENST00000540759; ENSP00000439878; ENSG00000166908. [Q8TBX8-1]
DR   Ensembl; ENST00000550465; ENSP00000447390; ENSG00000166908. [Q8TBX8-3]
DR   GeneID; 79837; -.
DR   KEGG; hsa:79837; -.
DR   UCSC; uc001sot.4; human. [Q8TBX8-1]
DR   CTD; 79837; -.
DR   DisGeNET; 79837; -.
DR   GeneCards; PIP4K2C; -.
DR   H-InvDB; HIX0201836; -.
DR   HGNC; HGNC:23786; PIP4K2C.
DR   HPA; HPA028658; -.
DR   HPA; HPA058551; -.
DR   neXtProt; NX_Q8TBX8; -.
DR   OpenTargets; ENSG00000166908; -.
DR   PharmGKB; PA162399665; -.
DR   eggNOG; KOG0229; Eukaryota.
DR   eggNOG; COG5253; LUCA.
DR   GeneTree; ENSGT00760000119184; -.
DR   HOGENOM; HOG000007832; -.
DR   HOVERGEN; HBG000072; -.
DR   InParanoid; Q8TBX8; -.
DR   KO; K00920; -.
DR   OMA; DFIANIF; -.
DR   OrthoDB; EOG091G0857; -.
DR   PhylomeDB; Q8TBX8; -.
DR   TreeFam; TF354315; -.
DR   BRENDA; 2.7.1.149; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-6811555; PI5P Regulates TP53 Acetylation.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8847453; Synthesis of PIPs in the nucleus.
DR   ChiTaRS; PIP4K2C; human.
DR   EvolutionaryTrace; Q8TBX8; -.
DR   GenomeRNAi; 79837; -.
DR   PRO; PR:Q8TBX8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000166908; -.
DR   CleanEx; HS_PIP4K2C; -.
DR   ExpressionAtlas; Q8TBX8; baseline and differential.
DR   Genevisible; Q8TBX8; HS.
DR   GO; GO:0005776; C:autophagosome; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016309; F:1-phosphatidylinositol-5-phosphate 4-kinase activity; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010506; P:regulation of autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0014066; P:regulation of phosphatidylinositol 3-kinase signaling; TAS:Reactome.
DR   Gene3D; 3.30.800.10; -; 1.
DR   Gene3D; 3.30.810.10; -; 1.
DR   InterPro; IPR023610; PInositol-4-P-5-kinase.
DR   InterPro; IPR027483; PInositol-4-P-5-kinase_C.
DR   InterPro; IPR002498; PInositol-4-P-5-kinase_core.
DR   InterPro; IPR027484; PInositol-4-P-5-kinase_N.
DR   PANTHER; PTHR23086; PTHR23086; 1.
DR   Pfam; PF01504; PIP5K; 1.
DR   SMART; SM00330; PIPKc; 1.
DR   PROSITE; PS51455; PIPK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    421       Phosphatidylinositol 5-phosphate 4-kinase
FT                                type-2 gamma.
FT                                /FTId=PRO_0000285750.
FT   DOMAIN       43    420       PIPK. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00781}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      26     26       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   VAR_SEQ      83    100       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043369.
FT   VAR_SEQ     124    171       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042929.
FT   VARIANT      84     84       V -> A (in dbSNP:rs17550713).
FT                                /FTId=VAR_032049.
FT   VARIANT     241    241       K -> R (in dbSNP:rs17852569).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_032050.
FT   VARIANT     300    300       A -> G (in dbSNP:rs2277319).
FT                                /FTId=VAR_032051.
FT   HELIX        46     62       {ECO:0000244|PDB:2GK9}.
FT   HELIX        73     77       {ECO:0000244|PDB:2GK9}.
FT   STRAND       79     85       {ECO:0000244|PDB:2GK9}.
FT   STRAND       87     89       {ECO:0000244|PDB:2GK9}.
FT   STRAND       92     94       {ECO:0000244|PDB:2GK9}.
FT   STRAND       96    104       {ECO:0000244|PDB:2GK9}.
FT   HELIX       105    113       {ECO:0000244|PDB:2GK9}.
FT   TURN        114    116       {ECO:0000244|PDB:2GK9}.
FT   HELIX       119    127       {ECO:0000244|PDB:2GK9}.
FT   STRAND      147    153       {ECO:0000244|PDB:2GK9}.
FT   HELIX       156    175       {ECO:0000244|PDB:2GK9}.
FT   STRAND      180    182       {ECO:0000244|PDB:2GK9}.
FT   STRAND      185    190       {ECO:0000244|PDB:2GK9}.
FT   STRAND      193    195       {ECO:0000244|PDB:2GK9}.
FT   STRAND      199    204       {ECO:0000244|PDB:2GK9}.
FT   STRAND      209    211       {ECO:0000244|PDB:2GK9}.
FT   HELIX       260    275       {ECO:0000244|PDB:2GK9}.
FT   HELIX       405    415       {ECO:0000244|PDB:2GK9}.
SQ   SEQUENCE   421 AA;  47300 MW;  65D1CBCF0826D476 CRC64;
     MASSSVPPAT VSAATAGPGP GFGFASKTKK KHFVQQKVKV FRAADPLVGV FLWGVAHSIN
     ELSQVPPPVM LLPDDFKASS KIKVNNHLFH RENLPSHFKF KEYCPQVFRN LRDRFGIDDQ
     DYLVSLTRNP PSESEGSDGR FLISYDRTLV IKEVSSEDIA DMHSNLSNYH QYIVKCHGNT
     LLPQFLGMYR VSVDNEDSYM LVMRNMFSHR LPVHRKYDLK GSLVSREASD KEKVKELPTL
     KDMDFLNKNQ KVYIGEEEKK IFLEKLKRDV EFLVQLKIMD YSLLLGIHDI IRGSEPEEEA
     PVREDESEVD GDCSLTGPPA LVGSYGTSPE GIGGYIHSHR PLGPGEFESF IDVYAIRSAE
     GAPQKEVYFM GLIDILTQYD AKKKAAHAAK TVKHGAGAEI STVHPEQYAK RFLDFITNIF
     A
//
